{"schema_version":"1","generated_at":"2026-11-04T12:00:45.608Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jasleen-randhawa","json_url":"https://www.findmykol.com/kol/jasleen-randhawa/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jasleen-randhawa","name":"Jasleen Randhawa","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Houston Methodist","institution_url":"https://www.findmykol.com/institution/houston-methodist","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1134305675","openalex":"A5109359142"},"summary":"Jasleen Randhawa is an Oncology physician affiliated with Houston Methodist. OpenAlex indexes 33 publications with 446 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":33,"cited_by_count":446,"h_index":11,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":4012.49,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134305675"},{"payer":"Medline Industries LP","program_year":2024,"amount_usd":22.41,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134305675"},{"payer":"Kite Pharma, Inc.","program_year":2022,"amount_usd":22.98,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134305675"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1134305675","source":"payments"},"publications":{"total":33,"shown":5,"withheld":28,"matched_by":"OpenAlex author record","recent":[{"title":"Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study","year":2023,"journal":"The Lancet Haematology","source_url":"https://doi.org/10.1016/s2352-3026(23)00338-1","status":"verified"},{"title":"P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES","year":2023,"journal":"HemaSphere","source_url":"https://doi.org/10.1097/01.hs9.0000969844.13426.20","status":"verified"},{"title":"POSTER: MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(23)00614-6","status":"verified"},{"title":"MDS-634 Efficacy and Safety of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subpopulation from Phase 2 and ASCERTAIN Phase 3 Studies","year":2023,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(23)01205-3","status":"verified"},{"title":"Reclassification of Ascertain (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) Based on IPSS-R and IPSS-M Scoring Systems","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-188258","status":"verified"}],"source":"works"},"contact":{"address_1":"6445 MAIN STREET","address_2":"OPC24","city":"Houston","state":"TX","zip":"77030","phone":"713-441-9948","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1134305675","source":"identity"},"similar":[{"name":"Neal Kleiman","slug":"neal-kleiman","institution":"Houston Methodist","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/neal-kleiman","json_url":"https://www.findmykol.com/kol/neal-kleiman/profile.json"},{"name":"William Zoghbi","slug":"william-zoghbi","institution":"Houston Methodist","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/william-zoghbi","json_url":"https://www.findmykol.com/kol/william-zoghbi/profile.json"},{"name":"Eleftherios Mylonakis","slug":"eleftherios-mylonakis","institution":"Houston Methodist","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/eleftherios-mylonakis","json_url":"https://www.findmykol.com/kol/eleftherios-mylonakis/profile.json"},{"name":"Dipan Shah","slug":"dipan-shah","institution":"Houston Methodist","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/dipan-shah","json_url":"https://www.findmykol.com/kol/dipan-shah/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":28}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-07-21","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}